Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Healthtrust
Federal Trade Commission
Julphar

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 6,057,298

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,057,298
Title: Keratin K1 expression vectors and methods of use
Abstract:A keratin K1 vector for expression of a nucleic acid sequence in an epidermal cell. The vector includes a 5\' flanking region which includes necessary sequences for expression of a nucleic acid cassette, a keratin K1 3\' flanking region which regulates expression of a nucleic acid sequence, predominantly in the epidermis, and a linker which connects the 5\' flanking region to a nucleic acid. The linker has a position for inserting a nucleic acid cassette. The linker does not contain the coding sequence of a gene that the linker is naturally associated with. That is, the linker is not the normal gene associated with the 5\' and 3\' regions.
Inventor(s): Roop; Dennis R. (Houston, TX), Rothnagel; Joseph A. (Houston, TX), Greenhalgh; David A. (Houston, TX), Yuspa; Stuart H. (Bethesda, MD)
Assignee: Baylor College of Medicine (Houston, TX) The United States of America as represented by the Department of Health (Washington, DC)
Application Number:08/452,872
Patent Claims:see list of patent claims

Details for Patent 6,057,298

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Baylor College of Medicine (Houston, TX) The United States of America as represented by the Department of Health (Washington, DC) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Baylor College of Medicine (Houston, TX) The United States of America as represented by the Department of Health (Washington, DC) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Baylor College of Medicine (Houston, TX) The United States of America as represented by the Department of Health (Washington, DC) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Express Scripts
Teva
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.